Generic Drugs Program Activities Report - FY 2023 Monthly Performance

This report provides monthly activities metrics for the FDA Generic Drugs Program, outlining agency actions on abbreviated new drug applications. Data includes approvals, applications received, complete responses, and more.

Source: FDA Center for Drug Evaluation and Research - What's New - December 12, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news